Wellcome Trust Research Round-Up: 27.10.14

Wellcome Trust Blog

Our fortnightly round-up of research news from the Wellcome Trust community…

Treating diabetes with light-activated drugs

A new method of treating type 2 diabetes has been developed by researchers at Imperial College London and LMU Munich. They have adapted currently used drugs so that they can be selectively activated using blue light. The hope is that this technique will improve treatment of diabetes by having fewer side effects than current treatments.

Dr David Hodson, one of the principal investigators on the project, said: “In principle, this type of therapy will give patients better control over their blood sugar because they can switch it on for a short time when it’s needed after a meal. It should also reduce complications by targeting drug activity to where it’s required in the pancreas”

Drugs called sulfonylureas stimulate the pancreas to produce more insulin and are widely prescribed to treat type 2 diabetes. However…

View original post 946 more words

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s